Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

346
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
346
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

138
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
138
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

127
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
127
Actuarial Approach01:20

Actuarial Approach

78
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
78
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

186
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
186

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prehabilitation for cancer surgery: a systematic review of qualitative literature from experienced stakeholders.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Regional Differences in the Delivery and Outcomes of Oesophageal Cancer Surgery Across Australia.

ANZ journal of surgery·2026
Same author

Barrett's oesophagus surveillance in a centralised system: implications for progression risk and management.

Journal of thoracic disease·2026
Same author

Assessment of methylated BCAT1 and IKZF1 circulating tumor DNA as a prognostic biomarker in esophagogastric adenocarcinomas.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2026
Same author

Five Advances for Benign Foregut Surgery in the Last 50 Years.

World journal of surgery·2026
Same author

Open Versus Hybrid and Total Minimally Invasive Transthoracic Ivor Lewis Esophagectomy Following Neoadjuvant FLOT Chemotherapy: An Australian and New Zealand Cohort Study.

World journal of surgery·2026

Related Experiment Video

Updated: Jul 2, 2025

Culture of Bladder Cancer Organoids as Precision Medicine Tools
08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

4.7K

Lessons from a population-based bladder cancer registry: exploring why survival is not improving.

Jake A Tempo1,2, Samuel Sii3, Joseph Ischia2

  • 1College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.

BJU International
|February 27, 2024
PubMed
Summary

Bladder cancer survival has declined over 40 years, primarily due to an aging population. Increased diagnoses in older individuals contribute to this trend, impacting overall survival rates.

Keywords:
bladder cancerelderlyolder peoplesurvivalurology

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

267
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

12.5K

Related Experiment Videos

Last Updated: Jul 2, 2025

Culture of Bladder Cancer Organoids as Precision Medicine Tools
08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

4.7K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

267
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

12.5K

Area of Science:

  • Oncology
  • Epidemiology
  • Public Health

Background:

  • Bladder cancer survival rates have shown a concerning decrease over the past four decades.
  • Understanding the factors contributing to this decline is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the reasons behind the observed decrease in bladder cancer survival over a 40-year period.
  • To analyze trends in bladder cancer incidence and survival in relation to demographic changes.

Main Methods:

  • Utilized data from the South Australian Cancer Registry spanning January 1977 to December 2020.
  • Included 8356 patients diagnosed with invasive bladder cancer (≥pT1 disease).
  • Analyzed changes in incidence, age at diagnosis, and survival, adjusting for age and other factors.

Main Results:

  • Invasive bladder cancer incidence decreased, but the mean age at diagnosis increased significantly (from 68 to 76 years).
  • Overall survival decreased, but this trend reversed after adjusting for age, indicating age as a key factor.
  • No significant change in bladder cancer-specific death rates was observed in older individuals, despite a decrease in non-cancer-specific deaths.

Conclusions:

  • The decrease in invasive bladder cancer survival is significantly influenced by the aging population structure.
  • While overall incidence has declined, the rise in diagnoses among older individuals is a primary driver of reduced survival rates.